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Abstract
Increasingly targeted in drug discovery, protein-protein interactions challenge current high 
throughput screening technologies in the pharmaceutical industry. Developing an effective and 
efficient method for screening small molecules or compounds is critical to accelerate the discovery 
of ligands for enzymes, receptors and other pharmaceutical targets. Here, we report developments 
of methods to increase the signal-to-noise ratio (SNR) for screening protein-protein interactions 
using atomic force microscopy (AFM) force spectroscopy. We have demonstrated the effectiveness 
of these developments on detecting the binding process between focal adhesion kinases (FAK) 
with protein kinase B (Akt1), which is a target for potential cancer drugs. These developments 
include optimized probe and substrate functionalization processes and redesigned probe-substrate 
contact regimes. Furthermore, a statistical-based data processing method was developed to 
enhance the contrast of the experimental data. Collectively, these results demonstrate the potential 
of the AFM force spectroscopy in automating drug screening with high throughput.
Keywords
Index Terms; Bionanotechnology; Nanosensors; Force spectroscopy; Atomic force microscopy; 
Protein-protein interactions
I. INTRODUCTION
The productivity of drug discovery has been an increasing concern in the past decade. Its 
limitations challenge the current business model of the pharmaceutical industry, and hinder 
the development of drugs for orphan diseases and diseases prevalent in undeveloped 
countries [1–3]. In the early stage of drug discovery, screening is applied to identify the 
“hits” from a library or from newly designed candidate drugs [4, 5]. The screening efficiency 
and effectiveness significantly affect the total productivity of drug discovery [6, 7]. To 
address this problem, many assays have been developed to screen compounds for 
pharmaceutical purposes. Biophysically, nuclear magnetic resonance (NMR), surface 
plasmon resonance (SPR), and isothermal titration calorimetry have been widely used [8]. 
Many biochemical assays, such as enzyme-linked immunosorbent assays (ELISA), 
fluorescence polarization, and fluorescence resonance energy transfer (FRET) are also 
common for this purpose [8].
Protein molecules mostly assemble together as a supramolecular complex to fulfill their 
physiological functions [9]. Playing a central role in physiological and pathological 
processes [10, 11], protein-protein interactions thus provide a rich source of potential 
therapeutic targets in drug discovery [12, 13]. Compared with traditional therapeutic targets, 
such as enzymes and G protein-coupled receptors, the interface of protein-protein 
interactions is large, often highly hydrophobic or charged. These unique characteristics of 
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protein-protein interactions challenge the widely used high-throughput screening 
technologies mentioned above [14]. Each of these technologies has its own strengths and 
weaknesses, but some weaknesses are common to many. Some of the methods require 
fluorescence labelling, which changes the biophysical characteristics of the target proteins 
[15]. In addition, these methods have high false positive rates in testing protein-protein 
interactions [16]. Thus, an urgent and significant need exists for developing an effective and 
efficient method for screening protein-protein interactions [3, 17].
Since its emergence, nanotechnologies have been impacting screening in drug discovery [18, 
19]. Among them, atomic force microscopy (AFM) was one of the earliest to be applied to 
drug discovery [20–23]. Not only can AFM image protein molecules in situ to investigate 
their morphology[24], but it also capable of measuring protein-protein interactions with 
pico-Newton (pN) resolution [25–29] to study their nanomechanical and adhesion properties 
[28–30]. This method was also used to analyse protein unfolding [29] and its structu 
characteristics [31]. AFM based force spectroscopy, quantifying the binding strength of 
protein affinity, has been considered as one of the promising candidates for drug screening 
[7, 32]. Using this method, the fluorescence staining process can be avoided, and the low 
false positive rate can achieved. Moreover, it can be equipped with other capabilities to 
achieve the high throughput needed for screening. A high-throughput drug discovery 
screening technique based on AFM force spectroscopy requires parallel and automated 
operations as well as integration with other biosensing technologies. To run the screening in 
parallel, the AFM system can be upgraded from a single cantilever to a cantilever array. In 
addition, th protein samples can also be patterned into arrays using state-ofthe-art patterning 
methods [33]. At present, several of these capabilities have been realized [34–36].
The application of AFM force spectroscopy on drug discovery suffers from low signal to 
noise ratio (SNR) as compared with other methods (Table I). Since drug screening aims to 
test whether the compounds promote or inhibit protein-protein interactions, the SNR in 
screening large number interactions is more important than accuracy. Though AFM force 
spectroscopy measures single molecular interactions with high resolution, a sufficient 
analysis requires hundreds of for curve measurements due to this low SNR.
Hence in this study, as initial steps toward developing an efficient screening method for 
inhibitors of protein-protein interactions, the process of AFM force spectroscopy was 
optimized to improve SNR. The characterization of Akt1 binding to FAK was selected as a 
prototypical example because of the clinical relevance of this molecular pair. Cancer cells 
upregulate their adhesiveness in response to physical forces, such as increased extracellular 
pressure and shear stress [44]. In this pathway, the binding of protein kinase B (Akt1) to 
focal adhesion kinase (FAK) is a critical step [45]. This biochemical response occurs in a 
variety of cancer types, including adenocarcinomas [45], squamous cell carcinomas [46], 
and even sarcomas [47]. Indeed, perturbing the interaction between FAK and Akt1 can 
substantially improve tumour-free survival in a mouse model [48]. Functionalizing FAK to 
an AFM probe and immobilizing Akt1 to a substrate, we first sought to improve the 
chemical functionalization method to minimize non-specific bindings. In addition, the AFM 
tip-substrate contact regimes were redesigned to ensure a robust interaction between the 
target molecules, including tip-substrate contact level and time, as well as the tip moving 
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speed. Furthermore, we developed a novel data processing method based on statistical 
analysis to enhance SNR and the contrast between control and experimental samples. 
Equipped with an AFM based nanorobotics platform, this development will pave the way for 
high throughput screening in drug discovery.
II. MATERIALS AND METHODS
A. Materials and reagents:
APTES ((3-Aminopropyl) triethoxysilane), N,N-Diisopropylethylamine (DIEA), 
triethylamine (TEA) and chloroform were purchased from Sigma Aldrich (St. Louis, MO). 
NHS-PEG-MAL was purchased from JenKem Technology (Plano, TX). SATP (N-
succinimidyl-S-acetylthiopropionate) and secondary antibody for fluorescence detecting 
were from Thermo Fisher Scientific (Waltham, MA). Akt1 molecules were purchased from 
Origene (Rockville, MD). PD-10 columns were purchased from GE Healthcare Life 
sciences (Pittsburgh, PA). The AFM system used in this research was a Bioscope from the 
Bruker (Santa Barbara, CA). AFM probes were also purchased from the Bruker.
B. AFM probe functionalization
To measure molecular interactions, the two proteins of interest were coated onto an AFM 
probe and a flat substrate, respectively. In this study, silicon nitride cantilevers with a spring 
constant of ~0.06 N/m were used. Before each experiment, the spring constant of the 
cantilevers was measured using the thermal tuning method [49]. The tip functionalization 
method was developed by H Schindler et al. [10].
First, the AFM probe was cleaned in chloroform for an hour. Cleaned probes were rinsed in 
fresh chloroform and blown dry by argon gas. Probes were then processed in an oxygen 
plasma cleaner to enhance the hydroxyl group density on the silicon nitride surface. APTES 
was subsequently coated onto the plasma treated AFM probes via gas phase deposition in a 
chamber filled with argon gas (APTES, 45 μl, DIEA, 15 μl). The APTES coated probes were 
then functionalized with PEG linker protein with its two ends grafted by NHS-and MAL-
groups (NHS-PEG-MAL). The PEG linker molecule-coated AFM probes were incubated in 
SATP-functionalized FAK (target protein) molecules for 2–3 hours. The functionalized 
probes were rinsed three times with phosphate buffered saline (PBS), and then stored in PBS 
at 4°C before use. To graft the FAK molecule with SATP, SATP solution was mixed with 
FAK solution, with the molar concentration of SATP 10 times higher than that of FAK to 
ensure that all FAK molecules were functionalized. After incubating the SATP-FAK mixture 
for 15 minutes, the solution was then eluted through a PD-10 column. 500 μl of SATP-FAK 
solution was dipped into a PD-10 column each time for 9 times. The 7th and 8th eluates were 
collected for usage.
C. Substrate functionalization
Akt1 molecules were directly deposited onto polystyrene (PS) substrate via hydrophobic 
interactions [50, 51]. Before each experiment, Akt1 molecules were incubated on the surface 
of a petri dish for 2 hours, and the dish was rinsed with PBS. Due to the hydrophobicity of 
polystyrene substrate, the Akt1 molecules were coated onto a local region of the petri dish 
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surface. Regions without coating in the same dish were used as a negative control. In another 
experimental condition, the Akt1 molecules were deposited via APTES linker molecule. 
Fresh mica substrates were first functionalized by APTES, by the same procedure described 
in the AFM probe functionalization section above. The Akt1 molecules then bind to the 
amino groups of APTES molecules.
D. Immunofluorescence staining
To visualized substrate functionalization, FAK molecules were deposited on to APTES 
coated mica substrate and polystyrene substrate. After coating, the samples were blocked in 
5% BSA solution for 1 hour. Following this, the samples were incubated in secondary 
fluorescence antibody solution for 1 hour in dark. The secondary antibody was Goat anti-
Mouse Secondary Antibody with Alexa Fluor 488 from Invitrogen. The samples were rinsed 
with PBS for three times, and five minutes each time. After that, the samples were imaged 
with Nikon fluorescence microscope TE1000 (Nikon Instruments Inc., Melville, NY, the 
USA). The images were captured by CoolSNAP HQ2 CCD Camera (Photometrics, Tucson, 
AZ), and processed using ImageJ (NIH, Bethesda, MD)
E. AFM based single molecular measurement
In this research, FAK molecules were fixed onto an AFM tip, while Akt1 was deposited onto 
a flat substrate. In the force spectroscopy experiment, forces rupturing the FAK-akt1 binding 
were measured by the deflection of the AFM cantilever. The rupture force of molecular pairs 
relaxed the AFM cantilever deflection during the retraction process, as represented by the 
sudden drop in measured force. To reduce the influence of capillary forces, and maintain the 
native conformation of protein molecules, AFM force spectroscopy experiments were 
performed in PBS. The moving range of the AFM probe was confined within 200 nm. The 
force spectroscopy was set to trigger mode with a triggering threshold of 5 nm. This 
parameter was also optimized ranging from 1 nm to 10 nm. For each experimental condition, 
a 20 by 20 array of spots was probed with a 500 nm pitch size. The tip moving velocity and 
contact level of the AFM tip were optimized in this study. The binding force was calculated 
using a customized script in MATLAB (MathWorks Inc.).
III. RESULT
A. Optimizing substrate functionalization to reduce non-specific bindings
APTES has been widely used as a linker molecule to functionalize the surface of mica, 
silicon or silicon nitride substrates [52–54]. In aqueous solutions, however, APTES 
molecules aggregate [55]. This uneven distribution will be translated to the non-uniform 
distribution of the protein molecules of interest, Akt1 (Fig. 1 (a)). In addition, APTES 
molecules are positively charged under physiological conditions, which increases their 
electrostatic interactions with the negative charged protein molecules on the AFM probe. 
Both factors increase the probability of undesired non-specific bindings. On APTES-coated 
substrates, the measured binding force between FAK molecules and the substrate increased 
significantly compared with data from substrates without APTES coating (Mica-APTES, 
Fig. 2 (a)). Depositing Akt1 molecules onto APTES coated mica substrates changed the 
distribution of binding force (Mica-APTES-AKT, Fig. 2 (b)). The 10 pN peak rose to more 
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than 60% in magnitude, signifying that non-specific binding events were amplified. The 
Akt1 molecules grafted on top of APTES significantly suppressed the binding probability of 
FAK to APTES. The peak located at around 80 pN (in Mica-APTES, Fig. 2(b)), representing 
the binding force between FAK and APTES molecules, disappeared. Meanwhile, the FAK-
Akt1 interactions require specific orientations of the two molecules. Thus, the binding 
probability of FAK-Akt1 is much lower than that of FAKAPTES. This increases the 
percentage of non-specific bindings, the peak at 10 pN. Further, due to the large binding 
force of FAK-APTES, the two distributions overlap significantly, making it difficult to 
distinguish the two interactions (Fig. 2 (b)).
To avoid the undesired bindings caused by APTES, Akt1 molecules were then deposited 
onto a fresh polystyrene (PS) substrate directly. The hydrophobic interactions of Akt1 with 
the PS substrate are much stronger than the specific binding between FAK and Akt1. Akt1 
molecules that are directly deposited onto fresh PS substrates exhibit significantly improved 
uniformity compared with Akt1 molecules binding to APTES functionalized PS substrates 
(Fig. 1 (b)). In addition, non-specific binding forces between the substrate and the FAK 
molecules increased from 10 pN in mica-APTES substrate to 30 pN in fresh PS substrate. 
However, the strong interactions between FAK and APTES were avoided (Fig. 2 (c)). Thus, 
it is easy to distinguish the interactions of FAK-Akt1 and FAK-PS. Binding forces in FAK-
PS were mainly restricted in the range smaller than 80 pN (PS, Fig. 2 (d)), while a large 
portion of FAK-Akt1 binding forces were greater than 80 pN. (AKT, Fig. 2 (d)).
In this drug discovery scenario, the signal here means interaction between FAK and Akt1 via 
specific interactive binding sites. Besides the strong non-specific binding forces from 
APTES, the non-specific binding between FAK and Akt1, and FAK and substrate also 
limited the SNR. Bovine serum albumin (BSA) has been widely used in 
immunofluorescence staining and western blotting to reduce the non-specific binding. In the 
context of AFM force spectroscopy, BSA coating to PS substrates increased the percentage 
of the non-specific binding forces at 30 pN in the experimental group from 45% (PS, Fig. 2 
(d)) to 80% (PS-BSA, Fig. 2 (e)). However, BSA blocking also reduced the possibilities of 
FAK-Akt1 interactions in experimental group, which decreased their binding forces (Fig. 2 
(e)). The peak in the histogram is at 75 pN. In both cases, the non-specific binding 
maintained as ~30 pN. Overall, the SNR was improved dramatically by coating the protein 
uniformly onto substrate and blocking with BSA.
B. Optimizing AFM tip-substrate interaction
The molecules on AFM tip interact with their counterparts on the substrate when they 
contact with each other. The characteristics of their contact regime, along with the 
mechanism of molecular interactions, determines the measured inter molecular forces. To 
improve the SNR, three parameters of the contact regime were optimized: level and time of 
AFM tip-substrate contact, and AFM tip moving speed during tip-substrate separation. The 
values used during experiments are provided in Table II.
1) AFM tip-substrate contact level—AFM tip-substrate contact level affects the 
distribution of the binding forces between FAK-Akt1 molecular pairs. AFM tip contact level 
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is related to the size of interface between surface molecules on the AFM probe and the 
substrate. Enlarging this interface will increase the number of FAK-Akt1 molecular pairs, 
which tends to increase the measured binding forces. To test this hypothesis, four contact 
levels were tested: 1 nm, 3 nm, 5 nm, and 10 nm. In FAK-PS negative control groups, tip 
contact depth affected the binding force minimally. As the depth increased from 1 nm to 10 
nm, larger binding forces emerged; however, the majority of the measured binding force is 
concentrated at 30 pN, which can be interpreted as noise (FAK-PS in Fig. 3 (e–h)). On the 
other hand, measured binding forces between FAK-Akt1 molecular pairs increased 
significantly with the increased contact levels. The peaks of the distribution were located at 
around 50 pN and 130 pN for 1 nm contact level, around 70 pN and 150 pN for 3 nm contact 
level, around 80 pN and 110 pN for 5 nm contact level, and around 80 pN, 144 pN and 215 
pN for 10 nm contact level (Fig. 3 (a–d)).
2) AFM tip-substrate contact time—Forming specific binding requires a particular 
orientation of the molecular pairs. Considering the time cost of orienting molecules, forming 
a specific binding might require a much longer time than forming a non-specific binding 
[56]. We therefore evaluated the effect of tip-substrate contact time on the measured binding 
force. Two tip-substrate contact times were tested: 500 ms and 1000 ms. In FAK-PS negative 
control group, the binding force histogram distribution maintained the same pattern with the 
two contact times: 98% and 93% of measured binding force is concentrated around peaks at 
24 pN and 36 pN for contact times of 500 ms and 1000 ms, respectively (FAK-PS, Fig. 4). 
In FAK-Akt1 experimental groups, the binding forces of FAK-Akt1 interactions are 
increased significantly. Two peaks occurred at 50 pN and 70 pN when the contact time 
increasing from 500 ms to 1000 ms (Fig. 4 (b)).
3) AFM tip moving speed—It has been reported that the moving speed of AFM tip 
affected the measured binding force significantly [57–59]. Increasing the tip moving speed 
increases the SNR [38]. Three moving speeds of the AFM tip were tested: 100 nm/s, 200 
nm/s, and 400 nm/s. In the FAK-PS case, the non-specific binding force increased as the 
moving speed of AFM tip is increased (FAK-PS, Fig. 5 (a–c)). However, this influence is 
minimal, as the binding forces mainly distributed in the range from 20 pN to 40 pN; 97%, 
94%, and 87% for tip moving speeds of 100 nm/s, 200 nm/s, and 400 nm/s, respectively, 
which is consistent with previous reports [58, 60]. In the FAK-Akt1 case, however, the best 
measurement occurred at a medium speed level, 200 nm/s (FAK-AKT, Fig. 5 (a–c)). At the 
speed of 200 nm/s, the measured FAK-Akt1 interactions exhibited a Gaussian distribution 
(Fig. 5 (b)). The peaks of the binding force are located at 60 pN and 80 pN for tip moving at 
100 nm/s and 200 nm/s. Two distribution peaks existed at 50 pN and 90 pN for tip moving 
speed at 400 nm/s. At the speed of 400 nm/s, the binding force at 30 pN, which interpreted 
as non-specific binding, increased to more than 50% compared (Fig. 5 (c)) with 30% and 
less than 5% at the tip moving speed at 100 nm/s and 200 nm/s (Fig. 5 (a and b)).
C. Statistical analysis-based data processing
Besides optimizing the experimental conditions, data processing and visualization methods 
also affects the perceived SNR. Assuming that the molecules on AFM tip has the same 
probabilities to form molecular pairs with the molecules on the substrate, the measured 
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AFM force spectroscopy data follow a Poisson distribution [61–63]. After mathematical 
manipulation, the binding force of single molecular pair can be estimated by the following 
equation [61]:
μm = μnFi + F0 (1)
σm
2 = σn
2 *Fi
2 = μmFi − FiF0 (2)
In this equation, μm and σm
2
 are the mean and standard deviation of the measured binding 
forces, Fi is the binding force is the mean number of molecular of a single molecular pair, μn 
is the sum of all non-specific bindings. A linear regression analysis of the measured data 
reveals the binding force of a single molecular pair, Fi. Assuming Fi does not change during 
the experiment, the experimental data with larger measured binding force will also have a 
larger standard deviation. Considering the binding force in experimental groups (FAK-Akt1) 
is much larger than that in negative control groups, the standard deviation should increase 
much faster in FAK-Akt1 than that in FAK-PS groups. Here we presented the mean value 
and standard deviation of the experimental data in different experimental conditions: the 
level and time of tip-substrate contact and AFM tip moving speeds. In all experimental 
conditions, the mean value of experimental and control groups is approximately 63.1 ± 24.7 
pN, and 27.5 ± 2.8 pN (mean ± SD), respectively (Fig. 6 (a, c, and e)). However, the 
standard deviation varies 10 to 100 times between these two groups (Fig. 6 (b, d, and f)). On 
average, the standard deviations of FAK-Akt1 and FAK-PS binding forces are 2311.1 
± 1226.1 pN2 and 70.7 ± 75.5 pN2, respectively. Thus, the standard deviation is a better 
parameter to enhance the contrast between experimental and negative control groups in 
screening drug candidates, as shown in Fig. 6.
IV. DISCUSSION
In this research, the substrate functionalization method and tip-substrate contact regime have 
been optimized to improve the SNR when measuring protein-protein interactions. Three 
factors in tip-substrate contact regime were optimized: the level and time of tip-substrate 
contact, and the tip moving speed before and after tip-substrate contact.
Directly depositing protein molecules onto PS substrates via hydrophobic interactions 
generates a uniform protein layer. One concern that might be raised is whether a monolayer 
of Akt1 molecules were deposited or not. We did not specifically prove that this deposition 
process creates a monolayer of molecules. However, we are ultimately trying to model 
FAKAkt1 interaction in living cells, where there are neither monolayers nor multilayers of 
Akt1, but where multiple different molecules may interact in suspension within the cytosol 
or in multi-protein complexes.
The measured protein-protein interactions with the new substrate functionalization method is 
in the same range reported previously. Specifically, there have been reports showing that 
non-specific binding forces below 10 pN [22]. Although, we have not been able to find 
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publications reporting the binding force between FAK and Akt1 molecules, with repeated 
experiments showing the peak binding forces at 80 pN, we have no reason to believe it is not 
the interaction force between FAK and Akt1. In fact, this force falls in the same range as 
other binding forces between a pair of protein molecules with affinity [22, 27].
Discrete Fourier transform, implemented by Fast Fourier transform (FFT), illuminates the 
periodic characters in discrete input data sequence as well as the relative strengths of each 
periodic component. The experimental data were analyzed by FFT to reveal their frequency 
distributions. Increasing tip-substrate contact levels narrowed the frequency distribution in 
negative control groups, FAK-PS. (Fig. 7 (a)). Larger binding forces emerged in deeper 
contact levels and expanded the range of measured binding forces. This enlarged range of 
force distributions decreases the energy at high frequencies. In the FAK-Akt1 group, 
increasing tip contact depth changed the distribution dramatically. As the contact depth 
increased, the relative amplitude strengths of higher frequencies increased. This means that 
more peaks with a small period exist. This is consistent with the analysis of the distribution. 
These results indicate that increasing contact depth increased the observed binding forces by 
forming more interacting molecular pairs. Together with the histogram data, FFT analysis 
results revealed that contact depth affects binding forces in the FAK-Akt1 experimental 
groups than that in the FAK-PS negative control groups. Furthermore, compared with other 
contact levels, the contact level of 5 nm has unique characteristics. In both FAKAkt1 and 
FAK-PS groups, the amplitude at high frequencies keep at low level. This character also 
presented as a single peak in the histogram (Fig. 3 (c and g)). Based on these results, we 
selected a depth of 5 nm for further experiment.
Regarding the tip-substrate contact time, FFT analysis further confirmed the minimal effect 
of contact time for negative control groups, with two curves almost overlapping with each 
other. (Fig. 7 (c)). This result is consistent with previous report [56]. In the FAK-Akt1 
groups, however, increasing tip-substrate contact time elevated the measured binding force 
significantly. The frequencies at larger binding forces increased at longer contact time. 
Binding and unbinding of FAK-Akt1 molecular pairs are dynamic processes, which require 
specific orientation of the target molecules. A longer reaction time permits the formation of 
more binding events before the reaction reaches equilibrium. FFT analysis presented a peak 
at 0.027 pN−1 (Fig. 7 (d)), which represent that a high component of period of 37 pN. This is 
consistent with histogram analysis.
Regarding the tip moving speeds during tip-substrate contact, in the FAK-PS group, as the 
moving speed increased, the percentage of binding forces at 20 pN is transferred to 30 pN 
and 40 pN. The FFT analysis also confirmed that the tip moving speed affected the binding 
force minimally in the negative control groups (Fig. 7 (e)). In the FAK-Akt1 group, FFT 
results revealed that most of the energy is distributed in low frequency ranges with tip 
moving speed at 200 nm/s, which is consistent with the single Gaussian distribution (Fig. 7 
(e)). At 200 nm/s, the SNR improved dramatically, as the overlap area between FAK-PS and 
FAK-AKT1 groups was significantly reduced. The average of FAK-AKT1 binding force is 
around 3 times larger than that of the FAK-PS group (Fig. 6(e)). Considering the standard 
deviation of the binding forces as the signal (Fig. 6(f)), the signal is 80 times larger than that 
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of the noise, as the standard deviation of the FAK-PS group. These results demonstrated that 
the methods improved the SNR significantly compared with previous reports [37, 38].
The existence of an optimal tip moving speed differs from the theoretical analysis in the 
literature which suggests that faster tip moving speed induces stronger binding forces [58, 
59]. This change might be due to the differences in experimental conditions. In previous 
studies, molecules were fixed to the substrate via a linker molecule or on gold surface [29, 
64]. The Akt1 molecules in the current study were directly deposited onto the substrate via 
hydrophobic interactions. The structure of a complex organic molecule will change during 
forming and breaking a molecular bond, which affects the number of available hydrophobic 
sites. The high rates of non-specific bindings in experimental group with 400 nm/s tip 
moving speed, indicated that the Akt1 molecules might be released from PS substrate. 
Collectively, these results demonstrated that an optimum moving speed exists for measuring 
the binding force in current experimental condition. Further mechanistic analysis is needed 
to fully understand this process.
This statistical analysis method for presenting the data also reveals new insights for the 
influences of different parameters on the measured binding forces. Increasing the tip-
substrate contact level increases the mean value, 23.3% and 33% in FAKAkt1 and FAK-PS 
groups, respectively (Fig. 6 (a, b)). However, the standard deviation increases 94% and 
85.4%, respectively. This means that contact depths increase the noises more than the 
signals. Tip-substrate contact time minimally affects negative control groups but increases 
the mean and standard deviation in the experimental group 29.1% and 14.7%, respectively 
(Fig. 6 (c, d)). This means that tip-substrate contact time mainly amplifies the signal with 
little effect on the noise level. The tip moving speed increases the mean value of the 
measured binding forces but does not affect their standard deviation in FAK-Akt1 groups. 
This is consistent with the data in the histogram. Moving speed mainly shifts the peak right 
and does not affect the range (Fig. 6 (e, f)). According to (2), this can be interpreted as the 
tip moving speed elevating the measured binding forces of a single molecular pair, 
consistent with previous models [59].
Certainly, there is more work to be done to combine all these advances to utilize AFM force 
spectroscopy as a high throughput screening technology. However, throughput may be a big 
hurdle if large numbers of replicates are required. We therefore sought here to improve the 
efficiency and effectiveness of the screening process itself by enhancing the SNR. In this 
way, the total number of force curves required to generate an identifiable contrast between 
experimental and control groups will be significantly reduced, thus increasing the 
throughput of this screening method.
V. CONCLUSION AND FUTURE PERSPECTIVES
In sum, toward developing an effective and efficient high throughput screening method for 
drug discovery using AFM force spectroscopy, the experimental settings were optimized to 
improve the SNR in screening protein-protein interactions. New substrate functionalization 
method was developed to reduce the noises. Experimental parameters, including the level 
and time of tip-substrate contact and tip moving speeds, were optimized towards this 
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application to enhance the SNR. A new data processing method based on statistical analysis 
was also developed to enhance the contrast between experimental and control groups. 
Collectively, these techniques may facilitate the development of an AFM based high 
throughput screening system.
Further, besides the high sensitivity of AFM force spectroscopy, it can also integrate with 
other biosensing or sample handling technologies. Integrating with microfluidics, the 
molecules involved in the screening process can be in small volume and be changed in a fast 
manner [65]. To minimize the size of the device and to simplify the design, the complicated 
laser based position sensing device can be replace by piezoelectric sensing device [66]. 
Fluorescence based biosensor can also be integrated with AFM force spectroscopy to 
characterize the protein-protein interaction both at single molecular and large volume level. 
These progresses, parallelizing and automating the system operation, integrating with other 
biosensing and system-enabling technologies, and optimizing interaction regimes presented 
in this paper, altogether formed a concrete foundation to develop an AFM force 
spectroscopy-enabled high-throughput screening of protein-protein interactions for drug 
discovery.
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Fig. 1. 
Directly depositing Akt1 molecules on polystyrene substrate improves the distribution of 
molecules on the substrate. (a) Fluorescence imaging of Akt1 molecules deposited onto an 
APTES functionalized mica substrate. (b) Fluorescence image of Akt1 molecules deposited 
onto a fresh polystyrene substrate. Scale bar: 10 μm.
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Fig. 2. 
Optimization of substrate functionalization method to reduce non-specific bindings. The Y 
axis, frequency, defines the ratio of data points in a specific binding force range and the total 
data points plotted. (a) Histogram of binding forces between FAK and APTES 
functionalized mica, and betwee FAK and fresh mica. (b) Histogram of binding forces 
between FAK and APTES functionalized mica, and between FAK and Akt1 on APTES 
functionalized mica. (c) Histograms of binding forces between FAK and PS (polystyrene), 
and between FAK and APTES functionalized mica. (d, and e) BSA blocking inhibits non-
specific binding between FAK and Akt1 molecules. Histogram of binding forces between 
FAK and Akt1 molecules without (d) and with (e) BSA blocking on PS substrate.
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Fig. 3. 
Optimization of the AFM tip contact level: increasing tip contact level increases the binding 
forces in FAK-Akt1 and FAK-PS, respectively. Histogram of binding forces of FAK-Akt1 at 
different contact levels: 1 nm (a), 3 nm (b), 5 nm (c), 10 nm (d). Histogram of binding forces 
of FAK-PS at different contact levels: 1 nm (e), 3 nm (f), 5 nm (g), 10 nm (h).
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Fig. 4. 
Optimization of the tip-substrate contact time. (a-b) Histogram o inding forces between 
FAK-Akt1 (blue bars) and FAK-PS (gray bars) with tip-substrate contact time as 500 ms (a) 
and 1000 ms (b).
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Fig. 5. 
Optimization of tip moving speed. Histogram of FAK-Akt1 and FAKPS binding forces with 
tip moving speeds at 100 nm/s (a), 200 nm/s (b), and 400 nm/s (c).
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Fig. 6. 
Standard deviation (SD) of binding force data presents the FAK-Akt1 and FAK-PS binding 
force with high contrast. (a, c and e) the mean of FAKAkt1 and FAK-PS binding forces with 
different: (a) tip-substrate contac levels, (c) tip-substrate contact times, and (e) tip moving 
speeds. (b, d and f) the mean of FAK-Akt1 and FAK-PS binding forces with different: (b) 
tip-substrate contact levels (d) tip indentation times, and (f) tip movin speeds.
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Fig. 7. 
Fast Fourier transform (FFT) analysis of the histogram data from measured binding forces in 
various experimental conditions. (a, b) FFT of the histogram data of binding forces between 
FAK-Akt1 (a) and FAK-PS (b) at different tip-substrate contact levels. (c, d) FFT of the 
histogram data binding forces between FAK-Akt1 (c) and FAK-PS (d) with different tip-
substrate contact times. (e, f) FFT of the histogram data of binding forces between FAK-
Akt1 (e) and FAK-PS (f) with the three tip moving speeds.
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Table I
SNR OF DRUG SCREEN METHODS
Technologies SNR
AFM force spectroscopy [37] [38] < 10
bioluminescence resonance energy transfer [39] 10
SWATH-mass spectrometry [40] > 20
surface plasmon resonance biosensor [41] 30
single molecular plasmonic biosensor [42] > 100
click chemistry enabled screening [43] > 10000
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TABLE II
PARAMETERS OF CONTACT REGIME
Parameter Contact level Contact time Tip moving speed
Contact level (nm) 1, 3, 5, 10 5 5
Contact time (ms) No delay 500, 1000 1000
Tip moving speed (nm/s) 100 100 100, 200, 400
Tip moving distance (nm) 200 200 200
Each column is an experimental condition during optimization.
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